What's new? Log in Free sign up

Filing search / Kineta, Inc. / "Pandemic"

Search information

Kineta, Inc.

Companies

"Pandemic"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

58 results

Newest first Best match first

KANT Kineta, Inc.

policies and procedures designed to help protect subjects from any future pandemic or public health crisis. For example, during the COVID-19 pandemic … that may materially impact our business and clinical development timelines. The ultimate impact of the COVID-19 pandemic on our business operations

21 Mar 24

4:06pm

KANT Kineta, Inc.

Quarterly report

of the disruptions to and volatility in the credit and financial markets in the United States and worldwide from the COVID-19 pandemic and the conflict … and worldwide resulting from the ongoing COVID-19 pandemic. If Kineta is unable to raise sufficient additional capital, Kineta could be forced to curtail its

11 May 23

5:22pm

KANT Kineta, Inc.

Definitive proxy

and identification of risks to our Company and the actions we are taking to mitigate risks related to health related matters, including the COVID-19 pandemic

28 Apr 23

5:09pm

KANT Kineta, Inc.

, the FDA issued a guidance, which the FDA subsequently updated, on conducting clinical trials during the pandemic. In June 2020, the FDA also issued … and policies that may materially impact our business and clinical development timelines. The ultimate impact of the COVID-19 pandemic on our business

31 Mar 23

4:05pm

KANT Kineta, Inc.

Kineta Reports Full Year 2022 Financial Results and Provides Corporate Update

of public health epidemics affecting countries or regions in which Kineta has operations or does business, such as the COVID-19 pandemic; the timing

fm6phzg2qxlv6qk3

Kineta Completes Reverse Merger with Yumanity Therapeutics

0ljgus7brp4n5pb3r4

Kineta Completes Reverse Merger with Yumanity Therapeutics

Kineta Completes Reverse Merger with Yumanity Therapeutics

Kineta Completes Reverse Merger with Yumanity Therapeutics

Kineta Completes Reverse Merger with Yumanity Therapeutics

0d61w9zgwcqk8mz5vag6

Quarterly report

14 Nov 22

8:44am

Prospectus supplement

Registration of securities issued in business combination transactions (amended)

4 Nov 22

4:49pm

Registration of securities issued in business combination transactions (amended)

24 Oct 22

9:14am

088b7gh0 osppu8

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

g35e v1qye3md7wj9

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

5opyrku9ds44hd7pr5

Registration of securities issued in business combination transactions

29 Aug 22

12:00am

172k3zdyim3ovgyig

Quarterly report

4 Aug 22

5:12pm

Business combination disclosure

g1sehnu 8zc9qlgf

Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.